A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
以念珠菌皮试试剂为基础的肽基人乳头瘤病毒治疗性疫苗作为新型疫苗佐剂用于治疗经活检证实的宫颈上皮内瘤变女性的 I 期剂量递增临床试验 2/3
期刊:Oncoimmunology
影响因子:
doi:10.1080/2162402X.2015.1031439
William W Greenfield, Shawna L Stratton, Rebecca S Myrick, Rita Vaughn, Lisa M Donnalley, Hannah N Coleman, Maria Mercado, Andrea M Moerman-Herzog, Horace J Spencer, Nancy R Andrews-Collins, Wilbur C Hitt, Gordon M Low, Nirvana A Manning, Samantha S McKelvey, Dora Smith, Michael V Smith, Amy M Phill